. 2025 Oct 30;5(6):677–697. doi: 10.21873/cdp.10484

Table II. Multivariate Cox regression analyses for DSS among the p62^highALDH1A3^high, p62^highALDH1A3^low, p62^lowALDH1A3^high and p62^lowALDH1A3^low groups of patients with the luminal breast cancer subtypes treated with or without endocrine therapy in the METABRIC dataset.

N.D.: Not determined; METABRIC: Molecular Taxonomy of Breast Cancer International Consortium; DSS: disease-specific survival; ALDH1A3:aldehyde dehydrogenase 1 family member A3. The hazard ratio of the p62^highALDH1A3^high group relative to the p62^high ALDH1A3^low, p62^low ALDH1A3^high and p62^lowALDH1A3^low groups was adjusted using age, chemotherapy and radiotherapy as confounding factors, as estimated using the Cox proportional hazard model. Significant differences are shown in bold

Table II. Multivariate Cox regression analyses for DSS among the p62highALDH1A3high, p62highALDH1A3low, p62lowALDH1A3high and p62lowALDH1A3low groups of patients with the luminal breast cancer subtypes treated with or without endocrine therapy in the METABRIC dataset.

Table II. Multivariate Cox regression analyses for DSS among the p62^highALDH1A3^high, p62^highALDH1A3^low, p62^lowALDH1A3^high and p62^lowALDH1A3^low groups of patients with the luminal breast cancer subtypes treated with or without endocrine therapy in the METABRIC dataset.